TOPAS Therapeutics
Laufzeit: 01.01.2019 - 31.12.2022
imported
Kurzfassung
“Harnessing tolerogenic antigen presentation in the liver to promote immunological tolerance in a mouse model of celiac disease.”
Laufzeit: 01.01.2019 - 31.12.2022
“Harnessing tolerogenic antigen presentation in the liver to promote immunological tolerance in a mouse model of celiac disease.”